LA Judge Throws Out $950 Million in J&J Talc Punitive Damages — Compensatory Award Stands

Los Angeles County Superior Court Judge Ruth Kwan vacated $950 million in punitive damages against Johnson & Johnson on March 13, issuing a judgment notwithstanding the verdict (JNOV) in the Mae Moore mesothelioma case. The $16 million compensatory damages award was upheld, along with the jury's finding that J&J's talc products caused Moore's cancer. Both sides plan to appeal.

The ruling arrives as J&J faces 67,115 pending cases in MDL-2738 — the largest active MDL in the federal court system — after three failed bankruptcy attempts to resolve the litigation. A January 2026 ruling by a federal special master greenlighting expert testimony on talc-ovarian cancer causation could pave the way for the first federal ovarian cancer trial later this year.

What the Judge Found

Judge Kwan's 100+ page ruling turned on a single question: did J&J actually know its talc products contained asbestos? Under California law, punitive damages require proof of malice, oppression, or fraud by "clear and convincing evidence" — a higher bar than the preponderance standard used for compensatory damages.

The judge found the evidence fell short. "A review of the entire record read in context and even in a light most favorable to plaintiffs reveals little, if anything, to suggest that J&J actually knew asbestos existed in its products," Kwan wrote. She pointed to "hundreds of test results" showing no asbestos in Johnson's Baby Powder and found that studies claiming to detect contamination "were retracted, could not be duplicated, or were otherwise debunked or questionable."

Critically, the judge also found that "when J&J learned that asbestos might be present, it acted to address those findings" — undermining the argument that the company deliberately disregarded a known risk.

The compensatory damages finding survived because it operates under a lower standard. The jury's conclusion that J&J's talc caused Moore's mesothelioma — and that the company was liable for $16 million in compensatory damages — was supported by sufficient evidence under the preponderance standard.

J&J's litigation VP Erik Haas called the ruling appropriate, stating the punitive award was "devoid of evidentiary support and patently unconstitutional." Moore's attorney Danny Kraft of Dean Omar Branham Shirley said the family "respectfully disagree[s] with the trial court's opinion and intend[s] to appeal."

The Broader Talc Litigation Landscape

The Moore ruling is one data point in a litigation that has produced wildly divergent outcomes. In December 2025, a Baltimore jury awarded $1.56 billion in the Cherie Craft mesothelioma case — including $1.5 billion in punitive damages — which remains intact pending appeal. The same month, a Minnesota jury awarded $65.5 million in a lung cancer case, and a California jury awarded $40 million in an ovarian cancer case.

In February 2026, a Philadelphia jury found J&J liable for ovarian cancer for the first time in that jurisdiction, though damages were modest at $250,000.

Three Bankruptcy Rejections

J&J's strategy to resolve the litigation through bankruptcy has been rejected three times. The company created subsidiary LTL Management in October 2021 and filed for bankruptcy, but courts found J&J was not in financial distress. A second attempt in April 2023 offered $8.9 billion over 25 years. The third attempt through Red River Talc in 2024 offered $10 billion but was rejected in March 2025 by Judge Christopher Lopez, who found that at least half of 90,000 claimant votes were invalid.

After the third rejection, J&J reversed its $7 billion litigation reserve and declared it would "litigate and defeat these meritless talc claims" individually.

The Federal Expert Testimony Ruling

Potentially more consequential than the Moore JNOV is the January 2026 ruling by retired Judge Freda Wolfson, acting as special master in MDL-2738. In a 658-page recommendation, she found that plaintiffs' experts "applied reliable methodologies" and that epidemiologic studies "demonstrate a positive, statistically significant association between genital talc powder use and ovarian cancer."

If adopted by the presiding judge, this ruling would allow the first federal ovarian cancer trial to proceed — opening a new front in litigation that has so far been concentrated in state courts and mesothelioma claims.

What This Means for Law Firms

The Evidentiary Bar for Punitive Damages

The Moore ruling clarifies the evidentiary threshold in California: plaintiffs must prove by clear and convincing evidence that J&J had actual knowledge of asbestos contamination — not just that contamination existed, but that the company knew about it and deliberately disregarded the risk. Judge Kwan's finding that J&J "acted to address" potential contamination when it was flagged suggests that evidence of responsive testing and remediation efforts can defeat punitive claims even when some tests showed positive results.

For firms evaluating talc inventory, this creates a two-track analysis: compensatory damages (where causation is sufficient) remain viable, but punitive damages require a stronger evidentiary foundation focused on corporate knowledge and intent.

Medical Records as the Foundation

In talc litigation, the medical evidence serves two functions. For compensatory damages, pathology reports confirming mesothelioma or ovarian cancer diagnosis, imaging and biopsy results, and treatment records establish the injury and its severity. For punitive damages, the evidence must go further — connecting the plaintiff's specific product use to the company's knowledge of contamination risk.

That means product use histories spanning decades, occupational and environmental records ruling out alternative asbestos exposure sources, and physician notes linking diagnosis to talc exposure are all critical. The strength of this documentation directly affects whether a case supports compensatory damages alone or both compensatory and punitive awards.

The Bottom Line

The Moore ruling does not signal the end of J&J talc litigation — it signals that punitive damages face a higher evidentiary bar than some plaintiffs' teams have cleared. The $1.56 billion Baltimore verdict remains intact. The federal expert testimony ruling opens a new path for ovarian cancer claims. And 67,115 cases continue to grow.

For firms with talc inventory, the takeaway is precision: compensatory damages require strong medical evidence of diagnosis and causation, while punitive damages require documented proof of corporate knowledge. Both start with complete medical records — pathology reports, treatment histories, and exposure documentation that can withstand the scrutiny of a JNOV motion.

Sources: Reuters, Legal Newsline/The Center Square, MDL Update, AP News, Reuters — Expert Testimony Ruling, Mesothelioma.net.